Impact on the population of different bone mineral density testing criteria and appropriateness of densitometries in the ESOSVAL cohort, Spain
- PMID: 24384018
- DOI: 10.1210/jc.2013-3448
Impact on the population of different bone mineral density testing criteria and appropriateness of densitometries in the ESOSVAL cohort, Spain
Abstract
Context: There is little consensus regarding which individuals should be recommended for bone mineral density (BMD) testing, a situation that could eventually affect the appropriateness of routine clinical practice.
Objectives: The aim of this study was to estimate the impact on the population of the application of the BMD testing criteria provided by the National Osteoporosis Guideline Group (NOGG), National Osteoporosis Foundation (NOF), and Osteoporosis Canada and to assess the appropriateness of the BMD tests currently performed.
Design: A cross-sectional study was conducted using the baseline data of the ESOSVAL cohort.
Participants: Participants included 11 035 men and women aged 50 years old and over attending primary health care centers in the Valencia region, Spain (2009-2010).
Main outcome and measures: BMD testing by dual-energy X-ray absorptiometry was recorded.
Results: Of the 10 710 people included in the study, 1617 (15.1%; 95% confidence interval [CI]: 14.4-15.8) received a BMD test. When applying the NOGG criteria, BMD testing would be recommended in 17.4% (95% CI: 16.7-18.1) of individuals, whereas this percentage would rise to 74.6% (95% CI: 73.7-75.4) and 80.1% (95% CI: 79.4-80.9) when using the Osteoporosis Canada and the NOF criteria, respectively. Regarding the appropriateness of the BMD tests performed in the ESOSVAL cohort, 40.7% (95% CI: 38.3-43.1), 86.0% (95% CI: 84.3-87.7), and 82.2% (95% CI: 80.3-84.1) of individuals having a BMD test met the NOGG, NOF, and the Canadian guidelines criteria, respectively. Of the tests performed, 40.7% would be deemed as appropriate, whereas 10.7% would be considered inappropriate.
Conclusions: The impact on the population of the different recommendations is enormous, varying from 17% to 80% of the population over 50 who would be tested. Although in men it seems that a clinical rationale exists between the presence of risk factors and the rates of BMD testing, this pattern does not seem to exist in women. One in 10 of the densitometric tests performed were inappropriate according to all the guidelines.
Similar articles
-
Impact of the NOGG and NOF Guidelines on the Indication of Bone Mineral Density in Routine Clinical Practice.J Clin Densitom. 2015 Oct-Dec;18(4):533-8. doi: 10.1016/j.jocd.2015.08.001. Epub 2015 Sep 3. J Clin Densitom. 2015. PMID: 26343823
-
Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry.JAMA. 2001 Jul 4;286(1):57-63. doi: 10.1001/jama.286.1.57. JAMA. 2001. PMID: 11434827
-
Pharmacist Screening for Risk of Osteoporosis in Elderly Veterans.Consult Pharm. 2016;31(8):440-9. doi: 10.4140/TCP.n.2016.440. Consult Pharm. 2016. PMID: 27535079
-
Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice.Am J Prev Med. 2009 Apr;36(4):366-75. doi: 10.1016/j.amepre.2009.01.013. Am J Prev Med. 2009. PMID: 19285200 Review.
-
Indications of DXA in women younger than 65 yr and men younger than 70 yr: the 2013 Official Positions.J Clin Densitom. 2013 Oct-Dec;16(4):467-71. doi: 10.1016/j.jocd.2013.08.002. Epub 2013 Sep 20. J Clin Densitom. 2013. PMID: 24055260 Review.
Cited by
-
Predictive Performance of the FRAX Tool Calibrated for Spain vs. an Age and Sex Model: Prospective Cohort Study with 9082 Women and Men Followed for up to 8 Years.J Clin Med. 2022 Apr 25;11(9):2409. doi: 10.3390/jcm11092409. J Clin Med. 2022. PMID: 35566539 Free PMC article.
-
Variations in osteoporosis medication utilization. A population-based ecological cross-sectional study in the region of Valencia, Spain.PLoS One. 2018 Jun 21;13(6):e0199086. doi: 10.1371/journal.pone.0199086. eCollection 2018. PLoS One. 2018. PMID: 29927952 Free PMC article.
-
Overuse and Underuse of Antiosteoporotic Treatments According to Highly Influential Osteoporosis Guidelines: A Population-Based Cross-Sectional Study in Spain.PLoS One. 2015 Aug 28;10(8):e0135475. doi: 10.1371/journal.pone.0135475. eCollection 2015. PLoS One. 2015. PMID: 26317872 Free PMC article.
-
Appropriateness of bone density measurement in Switzerland: a cross-sectional study.BMC Public Health. 2018 Apr 2;18(1):423. doi: 10.1186/s12889-018-5305-0. BMC Public Health. 2018. PMID: 29606111 Free PMC article.
-
Bone fractures and feeling at risk for osteoporosis among women in Japan: patient characteristics and outcomes in the National Health and Wellness Survey.Arch Osteoporos. 2014;9(1):199. doi: 10.1007/s11657-014-0199-7. Epub 2014 Nov 13. Arch Osteoporos. 2014. PMID: 25391755 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous